拜耳-话题@MedSci

#拜耳#

119篇内容 | 2999人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1318478, encodeId=f90113184e8de, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=拜耳通过进博会平台展示创新产品及解决方案, objectType=article, longId=152852, objectId=05271528528b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05271528528b, replyNumber=0, likeNumber=79, createdTime=2018-11-07, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05271528528b, moduleTitle=拜耳通过进博会平台展示创新产品及解决方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05271528528b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318477, encodeId=92f213184e7b0, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=拜耳旗下A型血友病药物Jivi在日本获批, objectType=article, longId=149519, objectId=5b97149519a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b97149519a1, replyNumber=0, likeNumber=55, createdTime=2018-09-26, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b97149519a1, moduleTitle=拜耳旗下A型血友病药物Jivi在日本获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b97149519a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318476, encodeId=d92c13184e6cd, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=拜耳，强生的Xarelto未能达到PhIII的目标, objectType=article, longId=147641, objectId=6c0214e64191, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c0214e64191, replyNumber=0, likeNumber=86, createdTime=2018-08-30, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c0214e64191, moduleTitle=拜耳，强生的Xarelto未能达到PhIII的目标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c0214e64191)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318475, encodeId=f4be13184e5c6, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=更佳心血管疾病药物公司TOP10 拜耳夺冠, objectType=article, longId=145603, objectId=822614560390, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=822614560390, replyNumber=0, likeNumber=54, createdTime=2018-08-02, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=822614560390, moduleTitle=更佳心血管疾病药物公司TOP10 拜耳夺冠, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=822614560390)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318474, encodeId=edab13184e471, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=拜耳赢得欧盟监管机构对更广泛的Xarelto使用的认可, objectType=article, longId=145544, objectId=7357145544c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7357145544c7, replyNumber=0, likeNumber=65, createdTime=2018-08-01, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7357145544c7, moduleTitle=拜耳赢得欧盟监管机构对更广泛的Xarelto使用的认可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7357145544c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318473, encodeId=c32e13184e3d0, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=拜耳肝癌治疗新药在华获批上市, objectType=article, longId=133137, objectId=8d0513313e3c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d0513313e3c, replyNumber=0, likeNumber=78, createdTime=2018-03-24, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d0513313e3c, moduleTitle=拜耳肝癌治疗新药在华获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d0513313e3c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318472, encodeId=9a6d13184e246, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=英国推出拜耳的五年避孕药Kyleena, objectType=article, longId=129560, objectId=a3431295601b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3431295601b, replyNumber=0, likeNumber=77, createdTime=2018-02-12, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3431295601b, moduleTitle=英国推出拜耳的五年避孕药Kyleena, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3431295601b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318471, encodeId=c52a13184e127, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=拜耳的Stivarga未被NICE纳入肝癌的治疗, objectType=article, longId=129524, objectId=a7e512952456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7e512952456, replyNumber=0, likeNumber=48, createdTime=2018-02-11, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7e512952456, moduleTitle=拜耳的Stivarga未被NICE纳入肝癌的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7e512952456)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318470, encodeId=3fa513184e02a, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=十年肝癌治疗领域新突破拜耳拜万戈在华获批肝癌适应症, objectType=article, longId=123190, objectId=6965123190f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6965123190f5, replyNumber=0, likeNumber=63, createdTime=2017-12-14, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6965123190f5, moduleTitle=十年肝癌治疗领域新突破拜耳拜万戈在华获批肝癌适应症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6965123190f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318469, encodeId=b386131846921, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=拜耳大力投入差异化药物研发产品线, objectType=article, longId=122489, objectId=d67112248908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d67112248908, replyNumber=0, likeNumber=82, createdTime=2017-12-08, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d67112248908, moduleTitle=拜耳大力投入差异化药物研发产品线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d67112248908)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318468, encodeId=802a131846811, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=拜耳/强生拜瑞妥® 预防静脉血栓栓塞, objectType=article, longId=94194, objectId=a0d894194ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0d894194ec, replyNumber=0, likeNumber=105, createdTime=2017-12-07, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0d894194ec, moduleTitle=拜耳/强生拜瑞妥® 预防静脉血栓栓塞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0d894194ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318467, encodeId=4d99131846ea8, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=拜耳授予中国初创企业“阿司匹林社会创新奖”特别奖, objectType=article, longId=122352, objectId=4a8d122352e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a8d122352e6, replyNumber=0, likeNumber=81, createdTime=2017-12-07, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a8d122352e6, moduleTitle=拜耳授予中国初创企业“阿司匹林社会创新奖”特别奖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a8d122352e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318466, encodeId=0d5f13184667b, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=CFDA批准拜耳多吉美®（索拉非尼）用于甲状腺癌的治疗, objectType=article, longId=121807, objectId=a6dc12180e77, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6dc12180e77, replyNumber=0, likeNumber=63, createdTime=2017-12-01, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6dc12180e77, moduleTitle=CFDA批准拜耳多吉美®（索拉非尼）用于甲状腺癌的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6dc12180e77)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318465, encodeId=994813184654f, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=拜耳的Stivarga被纳入NICE用于治疗胃肠道间质肿瘤, objectType=article, longId=120880, objectId=71d4120880c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71d4120880c2, replyNumber=0, likeNumber=96, createdTime=2017-11-22, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71d4120880c2, moduleTitle=拜耳的Stivarga被纳入NICE用于治疗胃肠道间质肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71d4120880c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318464, encodeId=cf3613184647e, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=Heiko Schipper将加入拜耳管理委员会担任健康消费品事业部负责人, objectType=article, longId=120490, objectId=f03f12049094, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f03f12049094, replyNumber=0, likeNumber=70, createdTime=2017-11-19, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f03f12049094, moduleTitle=Heiko Schipper将加入拜耳管理委员会担任健康消费品事业部负责人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f03f12049094)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318463, encodeId=5f471318463f3, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=十年 “走进西部”，拜耳全力支持中国基层医疗卫生服务, objectType=article, longId=120303, objectId=32a11203031b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32a11203031b, replyNumber=0, likeNumber=78, createdTime=2017-11-18, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32a11203031b, moduleTitle=十年 “走进西部”，拜耳全力支持中国基层医疗卫生服务, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32a11203031b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318462, encodeId=8e77131846258, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=拜耳助力“海贝后花园”爱心互动上海浦东新区辅读学校学生, objectType=article, longId=113781, objectId=6e8a113e8164, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e8a113e8164, replyNumber=0, likeNumber=79, createdTime=2017-09-24, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e8a113e8164, moduleTitle=拜耳助力“海贝后花园”爱心互动上海浦东新区辅读学校学生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e8a113e8164)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318461, encodeId=140b13184617b, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=“拜耳初创计划-上海2017”项目之“孵化器”计划选出4家初创企业, objectType=article, longId=111381, objectId=25d2111381c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25d2111381c6, replyNumber=0, likeNumber=60, createdTime=2017-09-01, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25d2111381c6, moduleTitle=“拜耳初创计划-上海2017”项目之“孵化器”计划选出4家初创企业, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25d2111381c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318460, encodeId=29581318460ef, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=拜耳：尽管作物科学业务有所下滑，集团业绩保持与去年持平, objectType=article, longId=107021, objectId=28bb10e02126, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28bb10e02126, replyNumber=0, likeNumber=58, createdTime=2017-07-30, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28bb10e02126, moduleTitle=拜耳：尽管作物科学业务有所下滑，集团业绩保持与去年持平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28bb10e02126)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1318459, encodeId=a46e131845991, content=<a href='/topic/show?id=9a535625968' target=_blank style='color:#2F92EE;'>#拜耳#</a>, objectTitle=让生命科学动起来拜耳健康生活馆北京站盛大开幕, objectType=article, longId=106674, objectId=873a1066e4af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=873a1066e4af, replyNumber=0, likeNumber=69, createdTime=2017-07-27, rootId=0, userName=ying_wu, userId=11b4465, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=873a1066e4af, moduleTitle=让生命科学动起来拜耳健康生活馆北京站盛大开幕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=873a1066e4af)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

拜耳

2020-05-29

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

拜耳通过进博会平台展示创新产品及解决方案

2018-11-07

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

拜耳旗下A型血友病药物Jivi在日本获批

2018-09-26

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

拜耳，强生的Xarelto未能达到PhIII的目标

2018-08-30

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

更佳心血管疾病药物公司TOP10 拜耳夺冠

2018-08-02

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

拜耳赢得欧盟监管机构对更广泛的Xarelto使用的认可

2018-08-01

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

拜耳肝癌治疗新药在华获批上市

2018-03-24

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

英国推出拜耳的五年避孕药Kyleena

2018-02-12

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

拜耳的Stivarga未被NICE纳入肝癌的治疗

2018-02-11

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

十年肝癌治疗领域新突破拜耳拜万戈在华获批肝癌适应症

2017-12-14

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

拜耳大力投入差异化药物研发产品线

2017-12-08

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

拜耳/强生拜瑞妥® 预防静脉血栓栓塞

2017-12-07

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

拜耳授予中国初创企业“阿司匹林社会创新奖”特别奖

2017-12-07

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

CFDA批准拜耳多吉美®（索拉非尼）用于甲状腺癌的治疗

2017-12-01

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

拜耳的Stivarga被纳入NICE用于治疗胃肠道间质肿瘤

2017-11-22

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

Heiko Schipper将加入拜耳管理委员会担任健康消费品事业部负责人

2017-11-19

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

十年 “走进西部”，拜耳全力支持中国基层医疗卫生服务

2017-11-18

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

拜耳助力“海贝后花园”爱心互动上海浦东新区辅读学校学生

2017-09-24

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

“拜耳初创计划-上海2017”项目之“孵化器”计划选出4家初创企业

2017-09-01

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

拜耳：尽管作物科学业务有所下滑，集团业绩保持与去年持平

2017-07-30

ying_wu (审核中...)

前往app查看评论内容

#拜耳#

让生命科学动起来拜耳健康生活馆北京站盛大开幕

2017-07-27

科室
- - 订阅+
  - 更多科室
工具
服务